Company intelligence / Profile preview

Meditrina

San Jose / Cupertino, California, USAmeditrina.gr ↗

Ownership: Private
Employees: ~240
Development stage: Other

Overview

Meditrina represents distinct entities in the life sciences sector. Meditrina, Inc. is a medical device company with FDA 510(k) clearance for its Gen 2 bipolar RF hysteroscopy device (Aveta System 2.0). Its device is commercially available, supported by $77M Series C financing, and is approaching cash flow positivity. Meditrina Pharmaceuticals (USA) is a clinical-stage pharmaceutical company with multiple women’s health programs, at least one in Phase 2 trials for reproductive disorders. Meditrina Pharmaceuticals Ltd in Greece operates within the Synapsis Group focusing on pharmaceutical activities.

Therapeutic areas: EndocrinologyWomen's HealthGastroenterology
Modalities: DeviceSmall molecule
Industry: Biotech

Partnerships

Deerfield Management CompanyShangBay CapitalSLR Capital PartnersSynapsis Group companies

Beyond the preview

Go deeper on Meditrina.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Meditrina.